Not Tripping over TRIPS: An Analysis of Necessity and Legality of the COVID-19 TRIPS Waiver Proposal

The availability of vaccinations against COVID-19 provides hope for containing the epidemic, which has already claimed over 2.84 million lives. However, inoculating millions of individuals worldwide would need large vaccine manufacturing followed by fair distribution. A barrier to vaccine development and dissemination is the developers' intellectual property rights. India and South Africa have jointly sought to the World Trade Organization that certain TRIPS rules of COVID-19 vaccines, medicines, and treatments be waived. This piece argues for such a waiver, highlighting the unique circumstances that exist. It believes that TRIPS's flexibilities are inadequate to cope with the present epidemic, particularly for nations without pharmaceutical manufacturing competence.

Site-Specific and Country-of-Origin Labeling for Pharmaceutical Manufacturing

There is increasing concern about the quality of pharmaceuticals, especially generics made in Asia. Popular books and news reports have the public questioning the quality of pharmaceuticals. Recalls and import bans shake confidence in medications, particularly for active pharmaceutical ingredients and finished dosage forms made outside the United States. The Food and Drug Administration uses geography to allocate resources for manufacturing surveillance. Site of manufacturing labeling, including the country, could be linked to the facility’s quality score to assess the risk of poor quality. Clinicians should advocate for legal and regulatory changes to increase the transparency of pharmaceutical manufacturing of products.

ANALYSIS OF THE ACTIVITIES OF PHARMACY AND PHARMACEUTICAL MANUFACTURING ORGANIZATIONS IN THE WESTERN REGION OF THE REPUBLIC OF KAZAKHSTAN IN ACCORDANCE WITH THE REQUIREMENTS OF THE INTERNATIONAL STANDARD GPP AND GMP

В статье рассмотрено современное состояния деятельности аптечных и фармацевтических производственных организаций Западного региона Республики Казахстан в соответствии требованиями международного стандарта GPP и GMP. Приведены результаты социологического опроса аптек по переходу международному стандарту GPP в городе Актобе. The article considers the current state of activity of pharmacy and pharmaceutical manufacturing organizations in the Western region of the Republic of Kazakhstan in accordance with the requirements of the international standard GPP and GMP. The results of a sociological survey of pharmacies on the transition to the international GPP standard in the city of Aktobe are presented.

Green Supply Chain Management and Competitive Advantage of Jordanian Pharmaceutical Industry

This research aims to investigate the effect of green supply chain management (GSCM) on the competitive advantage (CA) of Jordanian pharmaceutical manufacturing (JPM) organizations. Data were collected by questionnaires from managers who were working in JPM organizations, then checked and coded against SPSS. After confirming the tool validity, reliability, and relationship between variables, the hypotheses were tested by multiple regressions. The results show that JPM organizations implement green purchasing and green selling, while weakly implementing green operations. At the same time, for CA dimensions, the results show that JPM organizations are more concerned with quality, speed (time), and reliability than cost reduction and innovation. Moreover, the results show that the relationship between GSCM and CA is very strong. The results also show that green supply chain components affect the CA of JPM organizations, where green operations have the highest effect on total CA, followed by green purchasing and finally, green selling. Additionally, the green supply chain affects CA dimensions of JPM organizations, where GSCM has the highest effect on quality, followed by innovation, then time, while GSCM does not have any significant effect on reliability and cost.